Eagle Pharmaceuticals
EGRX
#10445
Rank
A$4.66 M
Marketcap
A$0.35
Share price
0.00%
Change (1 day)
-84.91%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: A$4.66 Million

As of March 2026 Eagle Pharmaceuticals has a market cap of A$4.66 Million. This makes Eagle Pharmaceuticals the world's 10445th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$4.66 M-46.41%
2025A$8.7 M-24.02%
2024A$11.45 M-88.51%
2023A$99.69 M-82.17%
2022A$0.55 B-38.36%
2021A$0.90 B14.93%
2020A$0.78 B-32.53%
2019A$1.16 B46.98%
2018A$0.79 B-22.06%
2017A$1.02 B-40.06%
2016A$1.70 B-10.5%
2015A$1.90 B615.91%
2014A$0.26 B

End of Day market cap according to different sources

On Mar 17th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
A$4.66 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$810.88 B 17,380,776.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$410.76 B 8,804,353.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$1.165 T 24,978,290.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$268.73 B 5,759,983.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$171.48 B 3,675,521.16%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$148.07 B 3,173,860.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$48.91 B 1,048,269.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel